Latest market price
28.38
+0.76+2.75%
ZBIOQT37Zenas BioPharma, Inc.·NASDAQ
28.38+2.75%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 13, 20268-KCurrent report
Sep 11, 2026S-3ASRS-3ASR
Sep 11, 2026S-8Registration of employee benefit securities
Sep 08, 2026SC 13GBeneficial ownership statement (passive)
Sep 08, 20263Initial statement of beneficial ownership
Sep 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 02, 20264Statement of changes in beneficial ownership
Sep 02, 20263Initial statement of beneficial ownership
Aug 19, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 17, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 13, 20268-KCurrent report
Aug 13, 202610-QQuarterly report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 13, 20268-KCurrent report